Cyproterone acetate

Cyproterone acetate is a synthetic steroidal anti-androgen with additional progestogenic activity, widely used in research for hormone-dependent conditions. +1

SKU: 427-51-0 Category: Tags: ,
Description
Cyproterone acetate is, furthermore, a high-potency steroidal pharmaceutical ingredient supplied by Zyntex for the clinical research, oncology, and endocrinology sectors. This white to off-white crystalline powder (CAS 427-51-0) is distinguished by its dual action as both a competitive androgen receptor antagonist and a potent progestin. In addition, it effectively suppresses the secretion of gonadotropins, leading to a significant reduction in testosterone levels. Therefore, it is extensively utilized as a primary therapeutic agent for hormone-sensitive oncology research and as a high-potential material for advanced endocrine regulation studies.

Comprehensive Product Overview

In the field of reproductive medicine and androgen-dependent pathology, the ability to selectively block dihydrotestosterone (DHT) binding is a major advantage. Cyproterone acetate is specifically selected because of its superior binding affinity compared to non-steroidal alternatives. For instance, it exhibits high lipophilicity, which ensures effective tissue distribution and prolonged biological half-life in lipid-based formulations. Consequently, it facilitates the development of targeted therapies for dermatological conditions such as severe acne and hirsutism. As a result, Zyntex ensures that our Cyproterone acetate is manufactured to strict pharmacopeial standards to ensure negligible levels of related steroidal impurities.

Moreover, the pharmaceutical-grade Cyproterone acetate provided by Zyntex is a vital component in the synthesis of combined hormonal therapies. This application allows for the creation of high-precision therapeutic regimens, undoubtedly pushing the boundaries of what is possible in gender-affirming healthcare and prostate research. At the same time, its role in clinical trials for paraphilia management is highly valued by global psychiatric research institutions. In short, our product serves as a dependable “hormonal-modulator” for companies focusing on both oncology therapeutics and sustainable endocrine health infrastructure.

Recently, scientific interest has surged regarding the use of low-dose Cyproterone in combination with estrogens to minimize metabolic side effects. Because of this, Zyntex offers specialized high-purity micronized formats to provide enhanced dissolution rates in laboratory environments. Ultimately, by choosing Zyntex as your supplier, you secure a reliable supply chain that balances molecular efficacy with rigorous quality assurance protocols. To conclude, our commitment to chemical excellence ensures that your manufacturing processes—whether in API synthesis or clinical research—achieve the highest levels of yield and structural integrity.

Key Industrial Applications

This high-potency steroid is specifically vital in the following four sectors:

🧬 Oncological Research

A vital agent for studying androgen-sensitive carcinomas; thus enabling the production of high-value cancer treatment models.

💊 Pharma Formulations

Key ingredient for anti-androgenic medications; consequently vital for the next generation of endocrine therapies.

🔬 Clinical Trials

Used as a reference standard for androgen receptor studies; undoubtedly essential for advanced drug discovery.

🧴 Dermatology Research

Used in formulations for androgenic skin disorders; specifically helping to control sebum production and terminal hair growth.

Technical Specifications

ParameterStandard Value
Product NameCyproterone Acetate
Assay / Purity98.0% – 102.0% (Dried Basis)
Molecular FormulaC24H29ClO4
CAS Number427-51-0

⚠️ Handling & Safety: Cyproterone acetate is a potent hormonal agent; therefore, it must be handled in a controlled environment using appropriate PPE. It is suspected of causing liver damage and influencing fetal development; consequently, strict containment measures are required during processing.